Physician profile
George C Mosch
NPI 1265471023
$2,532.64
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $256 · 2020: $320 · 2021: $1,023 · 2022: $526 · 2023: $407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $407.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $696.42 | 2019-2023 | Ozempic, Rybelsus, Saxenda |
| Abbvie INC. | $423.02 | 2019-2023 | |
| Pfizer INC. | $360.08 | 2019-2023 | |
| Lilly USA, LLC | $191.85 | 2019-2023 | Mounjaro |
| Astrazeneca Pharmaceuticals LP | $108.84 | 2019-2023 | Farxiga |
| Janssen Pharmaceuticals, INC | $90.44 | 2019-2021 | |
| Glaxosmithkline, LLC. | $87.73 | 2020-2023 | Shingrix, Arexvy, Trelegy Ellipta |
| Biohaven Pharmaceuticals, INC. | $72.94 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $45.45 | 2022 | |
| Boston Scientific Corporation | $44.37 | 2021-2022 | |
| Amarin Pharma, INC. | $43.94 | 2021 | |
| Merck Sharp & Dohme LLC | $41.26 | 2020-2021 | |
| Allergan, INC. | $39.11 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $32.04 | 2022 | |
| Amgen INC. | $28.94 | 2019-2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.57 | 2020-2021 | |
| Astellas Pharma US INC | $26.90 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $24.91 | 2023 | Opsumit, Uptravi |
| Nestle Healthcare Nutrition INC. | $22.31 | 2021 | |
| Abbott Laboratories | $17.81 | 2023 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $16.47 | 2021 | |
| Esperion Therapeutics, INC. | $14.87 | 2020 | |
| Novartis Pharmaceuticals Corporation | $13.84 | 2022 | |
| Exact Sciences Corporation | $13.65 | 2023 | Cologuard Collection Kit |
| Shire North American Group INC | $13.03 | 2019 | |
| Biogen, INC. | $12.02 | 2022 | |
| Sanofi Pasteur INC. | $11.82 | 2020 | |
| Medtronic Vascular, INC. | $11.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Mosch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.